Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anemia of malignancy

E P Frenkel1, R L Bick, C J Rutherford

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, USA.

Hematology/Oncology Clinics of North America
|August 1, 1996
PubMed
Summary

Anemia frequently accompanies cancer, potentially signaling the disease or worsening symptoms. Understanding its causes, like tumor cytokines, is key, as treatments like recombinant erythropoietin (EPO) can help manage this common cancer complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contaminants in heparins continue to be unfolded.

International angiology : a journal of the International Union of Angiology·2008
Same author

The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.

Clinical hemorheology and microcirculation·2007
Same author

DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers.

British journal of cancer·2005
Same author

Antiphospholipid thrombosis syndromes.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2001
Same author

Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard.

American journal of clinical pathology·2001
Same author

Third molar extractions in a patient with congenital afibrinogenemia: a case report.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·2001

Area of Science:

  • Oncology
  • Hematology

Background:

  • Anemia is a frequent complication of malignant diseases.
  • It can be an early indicator of cancer and impact patient symptoms and treatment choices.

Purpose of the Study:

  • To highlight the significance of anemia in cancer patients.
  • To discuss the underlying mechanisms of anemia in malignancy.
  • To emphasize the importance of identifying and treating treatable causes of anemia.

Main Methods:

  • Review of mechanisms contributing to anemia in cancer.
  • Discussion of the role of tumor-associated cytokines.
  • Consideration of erythropoietin (EPO) as a therapeutic option.

Main Results:

  • Anemia is a common and significant issue in cancer patients.
  • Tumor-produced cytokines are a major cause of cancer-related anemia.
  • Recombinant EPO can effectively counteract cytokine-induced anemia.

Conclusions:

  • Recognizing and addressing anemia is crucial in cancer care.
  • Understanding the pathophysiology of anemia in malignancy aids treatment.
  • Recombinant EPO offers a viable strategy to manage anemia of malignancy.

Related Experiment Videos